Hepatotoxicity and transaminase measurement during isoniazid chemoprophylaxis in children

Chemoprophylaxis with isoniazid (INH) prevents progression from tuberculosis infection to disease in >99% of children. INH is not completely free of side effects or risks, but these are uncommon. Although allergy, rash, gastrointestinal upset, peripheral neuropathy, seizures, encephalopathy and o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Pediatric infectious disease journal 1995-02, Vol.14 (2), p.144-148
Hauptverfasser: A, VINCENT, PALUSCI, OHARE, DONNA, LAWRENCE, ROBERT M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 148
container_issue 2
container_start_page 144
container_title The Pediatric infectious disease journal
container_volume 14
creator A, VINCENT
PALUSCI
OHARE, DONNA
LAWRENCE, ROBERT M
description Chemoprophylaxis with isoniazid (INH) prevents progression from tuberculosis infection to disease in >99% of children. INH is not completely free of side effects or risks, but these are uncommon. Although allergy, rash, gastrointestinal upset, peripheral neuropathy, seizures, encephalopathy and other reactions have been reported, the major side effect of INH is hepatitis. During 1993 a child was treated at our institution for fulminant hepatitis associated with INH. This prompted a review of the charts of all children treated at our children's chest clinic during the prior 2 years to assess the presentation of hepatotoxicity and the role of transaminase measurement during INH chemoprophylaxis in children.
doi_str_mv 10.1097/00006454-199502000-00012
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_16997168</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16997168</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4392-e99a2922e25aed713571e7def100297613ea85f148fcdc87d6a886d17538913f3</originalsourceid><addsrcrecordid>eNp1kUtP3DAQgK2qFSy0P6FSDqi3gB-JH0eEWkBC4gKHnqypPem6dZzFTgTbX1_TXfZWS5Zlzze25xtCGkbPGTXqgtYhu75rmTE95XXX1sn4O7JiveAtNVq9JyuqDWuFlPqYnJTyqyKiY_SIHCnVSWn0iny_wQ3M0zy9BBfmbQPJN3OGVGAMCQo2I0JZMo6Y5sYvOaSfTShTCvAn-MatcZw2edqstxFeQmlCqmch-ozpI_kwQCz4ab-eksdvXx-ubtq7--vbq8u71nXC8BaNAW44R94DesVErxgqjwOjlBslmUDQ_cA6PTjvtPIStJaeqV7U4sQgTsmX3b31H08LltmOoTiMERJOS7FMGqOY1BXUO9DlqZSMg93kMELeWkbtq1X7ZtUerNp_Vmvq5_0by48R_SFxr7HGz_ZxKA7iUAW6UA5Ylc41ZRXrdtjzFGfM5XdcnjHbNUKc1_Z_PRV_AaaskAs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16997168</pqid></control><display><type>article</type><title>Hepatotoxicity and transaminase measurement during isoniazid chemoprophylaxis in children</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>A, VINCENT ; PALUSCI ; OHARE, DONNA ; LAWRENCE, ROBERT M</creator><creatorcontrib>A, VINCENT ; PALUSCI ; OHARE, DONNA ; LAWRENCE, ROBERT M</creatorcontrib><description>Chemoprophylaxis with isoniazid (INH) prevents progression from tuberculosis infection to disease in &gt;99% of children. INH is not completely free of side effects or risks, but these are uncommon. Although allergy, rash, gastrointestinal upset, peripheral neuropathy, seizures, encephalopathy and other reactions have been reported, the major side effect of INH is hepatitis. During 1993 a child was treated at our institution for fulminant hepatitis associated with INH. This prompted a review of the charts of all children treated at our children's chest clinic during the prior 2 years to assess the presentation of hepatotoxicity and the role of transaminase measurement during INH chemoprophylaxis in children.</description><identifier>ISSN: 0891-3668</identifier><identifier>EISSN: 1532-0987</identifier><identifier>DOI: 10.1097/00006454-199502000-00012</identifier><identifier>PMID: 7746698</identifier><identifier>CODEN: PIDJEV</identifier><language>eng</language><publisher>Baltimore, MD: Williams &amp; Wilkins</publisher><subject>Adolescent ; Biological and medical sciences ; Chemical and Drug Induced Liver Injury - diagnosis ; Chemical and Drug Induced Liver Injury - enzymology ; Chemical and Drug Induced Liver Injury - etiology ; Child ; Child, Preschool ; Drug toxicity and drugs side effects treatment ; Female ; Humans ; Incidence ; Infant ; Isoniazid - adverse effects ; Isoniazid - therapeutic use ; Liver Function Tests ; Male ; Medical sciences ; Pharmacology. Drug treatments ; Prognosis ; Retrospective Studies ; Toxicity: digestive system ; Transaminases - blood ; Tuberculosis - drug therapy</subject><ispartof>The Pediatric infectious disease journal, 1995-02, Vol.14 (2), p.144-148</ispartof><rights>Williams &amp; Wilkins 1995. All Rights Reserved.</rights><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4392-e99a2922e25aed713571e7def100297613ea85f148fcdc87d6a886d17538913f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3412801$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7746698$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>A, VINCENT</creatorcontrib><creatorcontrib>PALUSCI</creatorcontrib><creatorcontrib>OHARE, DONNA</creatorcontrib><creatorcontrib>LAWRENCE, ROBERT M</creatorcontrib><title>Hepatotoxicity and transaminase measurement during isoniazid chemoprophylaxis in children</title><title>The Pediatric infectious disease journal</title><addtitle>Pediatr Infect Dis J</addtitle><description>Chemoprophylaxis with isoniazid (INH) prevents progression from tuberculosis infection to disease in &gt;99% of children. INH is not completely free of side effects or risks, but these are uncommon. Although allergy, rash, gastrointestinal upset, peripheral neuropathy, seizures, encephalopathy and other reactions have been reported, the major side effect of INH is hepatitis. During 1993 a child was treated at our institution for fulminant hepatitis associated with INH. This prompted a review of the charts of all children treated at our children's chest clinic during the prior 2 years to assess the presentation of hepatotoxicity and the role of transaminase measurement during INH chemoprophylaxis in children.</description><subject>Adolescent</subject><subject>Biological and medical sciences</subject><subject>Chemical and Drug Induced Liver Injury - diagnosis</subject><subject>Chemical and Drug Induced Liver Injury - enzymology</subject><subject>Chemical and Drug Induced Liver Injury - etiology</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Female</subject><subject>Humans</subject><subject>Incidence</subject><subject>Infant</subject><subject>Isoniazid - adverse effects</subject><subject>Isoniazid - therapeutic use</subject><subject>Liver Function Tests</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>Toxicity: digestive system</subject><subject>Transaminases - blood</subject><subject>Tuberculosis - drug therapy</subject><issn>0891-3668</issn><issn>1532-0987</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kUtP3DAQgK2qFSy0P6FSDqi3gB-JH0eEWkBC4gKHnqypPem6dZzFTgTbX1_TXfZWS5Zlzze25xtCGkbPGTXqgtYhu75rmTE95XXX1sn4O7JiveAtNVq9JyuqDWuFlPqYnJTyqyKiY_SIHCnVSWn0iny_wQ3M0zy9BBfmbQPJN3OGVGAMCQo2I0JZMo6Y5sYvOaSfTShTCvAn-MatcZw2edqstxFeQmlCqmch-ozpI_kwQCz4ab-eksdvXx-ubtq7--vbq8u71nXC8BaNAW44R94DesVErxgqjwOjlBslmUDQ_cA6PTjvtPIStJaeqV7U4sQgTsmX3b31H08LltmOoTiMERJOS7FMGqOY1BXUO9DlqZSMg93kMELeWkbtq1X7ZtUerNp_Vmvq5_0by48R_SFxr7HGz_ZxKA7iUAW6UA5Ylc41ZRXrdtjzFGfM5XdcnjHbNUKc1_Z_PRV_AaaskAs</recordid><startdate>199502</startdate><enddate>199502</enddate><creator>A, VINCENT</creator><creator>PALUSCI</creator><creator>OHARE, DONNA</creator><creator>LAWRENCE, ROBERT M</creator><general>Williams &amp; Wilkins</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>199502</creationdate><title>Hepatotoxicity and transaminase measurement during isoniazid chemoprophylaxis in children</title><author>A, VINCENT ; PALUSCI ; OHARE, DONNA ; LAWRENCE, ROBERT M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4392-e99a2922e25aed713571e7def100297613ea85f148fcdc87d6a886d17538913f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Adolescent</topic><topic>Biological and medical sciences</topic><topic>Chemical and Drug Induced Liver Injury - diagnosis</topic><topic>Chemical and Drug Induced Liver Injury - enzymology</topic><topic>Chemical and Drug Induced Liver Injury - etiology</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Female</topic><topic>Humans</topic><topic>Incidence</topic><topic>Infant</topic><topic>Isoniazid - adverse effects</topic><topic>Isoniazid - therapeutic use</topic><topic>Liver Function Tests</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>Toxicity: digestive system</topic><topic>Transaminases - blood</topic><topic>Tuberculosis - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>A, VINCENT</creatorcontrib><creatorcontrib>PALUSCI</creatorcontrib><creatorcontrib>OHARE, DONNA</creatorcontrib><creatorcontrib>LAWRENCE, ROBERT M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>The Pediatric infectious disease journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>A, VINCENT</au><au>PALUSCI</au><au>OHARE, DONNA</au><au>LAWRENCE, ROBERT M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hepatotoxicity and transaminase measurement during isoniazid chemoprophylaxis in children</atitle><jtitle>The Pediatric infectious disease journal</jtitle><addtitle>Pediatr Infect Dis J</addtitle><date>1995-02</date><risdate>1995</risdate><volume>14</volume><issue>2</issue><spage>144</spage><epage>148</epage><pages>144-148</pages><issn>0891-3668</issn><eissn>1532-0987</eissn><coden>PIDJEV</coden><abstract>Chemoprophylaxis with isoniazid (INH) prevents progression from tuberculosis infection to disease in &gt;99% of children. INH is not completely free of side effects or risks, but these are uncommon. Although allergy, rash, gastrointestinal upset, peripheral neuropathy, seizures, encephalopathy and other reactions have been reported, the major side effect of INH is hepatitis. During 1993 a child was treated at our institution for fulminant hepatitis associated with INH. This prompted a review of the charts of all children treated at our children's chest clinic during the prior 2 years to assess the presentation of hepatotoxicity and the role of transaminase measurement during INH chemoprophylaxis in children.</abstract><cop>Baltimore, MD</cop><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>Williams &amp; Wilkins</pub><pmid>7746698</pmid><doi>10.1097/00006454-199502000-00012</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0891-3668
ispartof The Pediatric infectious disease journal, 1995-02, Vol.14 (2), p.144-148
issn 0891-3668
1532-0987
language eng
recordid cdi_proquest_miscellaneous_16997168
source MEDLINE; Journals@Ovid Complete
subjects Adolescent
Biological and medical sciences
Chemical and Drug Induced Liver Injury - diagnosis
Chemical and Drug Induced Liver Injury - enzymology
Chemical and Drug Induced Liver Injury - etiology
Child
Child, Preschool
Drug toxicity and drugs side effects treatment
Female
Humans
Incidence
Infant
Isoniazid - adverse effects
Isoniazid - therapeutic use
Liver Function Tests
Male
Medical sciences
Pharmacology. Drug treatments
Prognosis
Retrospective Studies
Toxicity: digestive system
Transaminases - blood
Tuberculosis - drug therapy
title Hepatotoxicity and transaminase measurement during isoniazid chemoprophylaxis in children
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T10%3A47%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hepatotoxicity%20and%20transaminase%20measurement%20during%20isoniazid%20chemoprophylaxis%20in%20children&rft.jtitle=The%20Pediatric%20infectious%20disease%20journal&rft.au=A,%20VINCENT&rft.date=1995-02&rft.volume=14&rft.issue=2&rft.spage=144&rft.epage=148&rft.pages=144-148&rft.issn=0891-3668&rft.eissn=1532-0987&rft.coden=PIDJEV&rft_id=info:doi/10.1097/00006454-199502000-00012&rft_dat=%3Cproquest_cross%3E16997168%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16997168&rft_id=info:pmid/7746698&rfr_iscdi=true